Skip to content

An experiment to examine the efficacy of community participatory interventions to prevent suicide

A community randomized controlled trial design to examine the efficacy of community participatory interventions to prevent suicide

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220620003
Enrollment
588
Registered
2022-06-20
Start date
2022-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Our primary health outcome is the severity of suicidality in suicide-risk patients, including patients who have experienced suicide attempts, chronic mental illnesses, chronic non-communicable diseases, or an acute life crisis. In our study, chronic mental illnesses cover schizophrenia, bipolar disorder, depressive disorder, and alcohol and substance use disorders. Chronic non-communicable diseases include cancers, cardiovascular, diabetes, hypertension and chronic respiratory diseases. The seve

Interventions

The studied intervention consists of two parts. Part 1 of the intervention includes a series of capacity building workshops for relevant key stakeholders at the sub-district level and the community le
Experimental Behavioral,No Intervention No treatment
Community participatory interventions to prevent suicide,Service as usual

Sponsors

Thai Health Promotion Foundation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who have used health services and been recorded in health records in the studied sub-district health centres, both intervention and control sub-districts. 2. Patients who have at least one of the following chronic mental illnesses: schizophrenia, bipolar disorder, depressive disorder, and alcohol and substance use disorders 3. Patients who have at least one of the following chronic non-communicable diseases: cancers, cardiovascular, diabetes, hypertension and chronic respiratory diseases 4. Patients who have experienced an acute life crisis

Exclusion criteria

Exclusion criteria: 1. Patients who move out of the studied areas during the study period 2. Patients who have too many symptoms to cooperate in data collection 3. Patients who cannot communicate using the Thai language

Design outcomes

Primary

MeasureTime frame
The severity of suicidality At baseline before starting the studied interventions, and one-year and two-year after starting the studied interventions The severity of suicidality is measured by the 8-question scale (8Q) developed by the Department of Mental Health, Ministry of Public Health.

Secondary

MeasureTime frame
Depressive symptom at baseline before starting the studied interventions, and one year and two-year after starting the studied interventions PHQ-2 and PHQ-9,Quality of life at baseline before starting the studied interventions, and one year and two-year after starting the studied interventions EQ-5D-5L,Stress level at baseline before starting the studied interventions, and one year and two-year after starting the studied interventions 5-item stress test,accessibility to suicide-prevention health service at baseline before starting the studied interventions, and one year and two-year after starting the studied interventions suicide-prevention health service accessibility assessment questionnaire ,accessibility to suicide-prevention community service at baseline before starting the studied interventions, and one year and two-year after starting the studied interventions suicide-prevention community service accessibility assessment questionnaire

Countries

Thailand

Contacts

Public ContactBundit Sornpaisarn

University of Toronto, Dalla lana school of public health

bundit.sornpaisarn@alum.utoronto.ca0818828622

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026